BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14

• Press Releases

  CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

  August 3, 2026

   · 

  18 min read
• Press Releases

  AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards

  August 3, 2026

   · 

  5 min read
• Press Releases

  SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance

  August 3, 2026

   · 

  11 min read
• Press Releases

  Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - August 3, 2026

  August 3, 2026

   · 

  2 min read
• Press Releases

  Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026

  August 3, 2026

   · 

  1 min read
• Press Releases

  Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026

  August 3, 2026

   · 

  1 min read
• Press Releases

  Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

  August 3, 2026

   · 

  12 min read
• Press Releases

  Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 3, 2026

  August 3, 2026

   · 

  2 min read
• Press Releases

  Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 3, 2026

  August 3, 2026

   · 

  1 min read
• Press Releases

  ORIC® Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates

  August 3, 2026

   · 

  9 min read